Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor plus aspirin vs clopidogrel in acute ischemic stroke
IRCT20250602066018N1Phase 3Recruiting
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ticagrelor, aspirin and clopidogrel in ischemic stroke (2 arms), sponsored by Qazvin University of Medical Sciences. Started Jun 2025; status: recruiting.
02
Drugs
ticagreloraspirinclopidogrel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20250602066018N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250602066018N1.